Showing results (41-50 of 53) with videos related to
Sort By:
Pageof 6
Pediatric Blood & Cancer|June 14, 2021
Pyruvate kinase deficiency in childrenSatheesh Chonat, Stefan W Eber, Susanne Holzhauer, et al.Lancet (London, England)|August 2, 2015
Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trialJohn D Grainger, Franco Locatelli, Thirachit Chotsampancharoen, et al.Research and Practice in Thrombosis and Haemostasis|July 12, 2019
Impact of prophylaxis on health-related quality of life of boys with hemophilia: An analysis of pooled data from 9 countriesKoyo Usuba, Victoria E Price, Victor Blanchette, et al.Journal of Thrombosis and Haemostasis : JTH|March 22, 2026
Systematic review on the design and methodology of the pediatric direct oral anticoagulant clinical trials for thrombosis prevention: Communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and HemostasisHilary Whitworth, Marisol Betensky, Rukhmi V Bhat, et al.Medicine|October 1, 2019
Severe infections of Panton-Valentine leukocidin positive Staphylococcus aureus in childrenPia-Alice Hoppe, Susanne Holzhauer, Birgit Lala, et al.The Lancet. Haematology|August 18, 2019
Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studiesPaul Monagle, Anthonie W A Lensing, Kirstin Thelen, et al.Journal of Thrombosis and Haemostasis : JTH|April 5, 2020
Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr phase 3 dose-exposure-response evaluationGuy Young, Anthonie W A Lensing, Paul Monagle, et al.American Journal of Hematology|February 12, 2020
Genotype-phenotype correlation and molecular heterogeneity in pyruvate kinase deficiencyPaola Bianchi, Elisa Fermo, Kimberly Lezon-Geyda, et al.Circulation|April 14, 2010
Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: a systematic review and meta-analysis of observational studiesGili Kenet, Lisa K Lütkhoff, Manuela Albisetti, et al.The Lancet. Haematology|November 9, 2019
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trialChristoph Male, Anthonie W A Lensing, Joseph S Palumbo, et al.Pageof 6